行情

KMPH

KMPH

KemPharm
NASDAQ

实时行情|Nasdaq Last Sale

0.3734
-0.0166
-4.26%
休市 16:00 12/13 EST
开盘
0.3900
昨收
0.3900
最高
0.4081
最低
0.3700
成交量
10.08万
成交额
--
52周最高
2.850
52周最低
0.3339
市值
1,240.58万
市盈率(TTM)
-0.4184
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

KMPH 新闻

  • 泰国和俄罗斯计划2020年使两国贸易额达到100亿美元
  • 新浪财经综合.13小时前
  • 亏损不断扩大 阿斯顿-马丁将引入新投资者
  • 新浪财经-自媒体综合.13小时前
  • 马斯克:太阳能、能源存储业务将超越电动车业务
  • 新浪美股.14小时前
  • iPhone降到1999就能统治市场?其他手机笑出声
  • 新浪财经综合.15小时前

更多

所属板块

生物技术和医学研究
+1.07%
制药与医学研究
-0.32%

热门股票

名称
价格
涨跌幅

KMPH 简况

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. The Company's product candidate, KP201/APAP, consists of KP201, its prodrug of hydrocodone, which is combined with acetaminophen (APAP). The Company is developing KP201/APAP as an immediate release (IR), a product candidate for the short-term, or no longer than 14 days for the management of acute pain. The Company has designed KP201/APAP with abuse-deterrent properties to address the epidemic of opioid abuse in the United States. The Company also focuses on developing the pipeline of additional prodrug product candidates that targets pain and attention deficit hyperactivity disorder (ADHD). The Company's products include KP201/IR (APAP-free), KP511/ER, KP415, KP606/IR and KP746.
展开

Webull提供KemPharm Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。